Erlotinib vs Lithium Carbonate
Erlotinib vs Lithium Carbonate: Overview
This comparison examines the pharmacological differences between Erlotinib and Lithium Carbonate.
Mechanism of Action
Erlotinib: Reversible inhibitor of EGFR (HER1) tyrosine kinase, blocking autophosphorylation.
Lithium Carbonate: Modulates intracellular signaling via inositol and GSK-3 inhibition.
Pharmacokinetics
Half-life: Erlotinib β 36 hours; Lithium Carbonate β 18-36 hours.
Chemical Properties
Molecular Formula: Erlotinib β C22H23N3O4; Lithium Carbonate β Li2CO3.
Molecular Weight: Erlotinib β 393.4380 g/mol; Lithium Carbonate β 73.8910 g/mol.
Type: Erlotinib β Small molecule; Lithium Carbonate β Small molecule.